Silo Pharma, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
NV
Business Address
677 N. WASHINGTON BLVD, SARASOTA, FL, 34236
Mailing Address
677 N. WASHINGTON BLVD, SARASOTA, FL, 34236
Phone
(718) 400-9031
Fiscal Year End
1231
EIN
462137136
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | April 2, 2026 | View on SEC |
| 10-K Annual financial report | March 27, 2026 | View on SEC |
| 8-K Current report of material events | February 23, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 13, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 13, 2026 | View on SEC |
| 8-K Current report of material events | December 29, 2025 | View on SEC |
| 4 Insider stock transaction report | December 16, 2025 | View on SEC |
| 4 Insider stock transaction report | November 21, 2025 | View on SEC |
| 4 Insider stock transaction report | November 20, 2025 | View on SEC |
Annual Reports
10-K
March 27, 2026
- Lead drug candidate SPC-15 for PTSD/Anxiety secured a faster FDA approval path.
- Development of SP-26 ketamine implant for pain relief as an opioid alternative.
Material Events
8-K
Financial Distress
December 29, 2025
High Impact
- Silo Pharma, Inc. received an extension from Nasdaq to regain compliance with the $1.00 minimum bid price rule.
- The new deadline for the company to meet the listing requirement is June 22, 2026.
Insider Trading
BUY
1 insiders
6 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.